Frankfurt - Delayed Quote EUR
Vanda Pharmaceuticals Inc. (VM4.F)
3.7800
-0.0800
(-2.07%)
As of 8:04:42 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
198,772
198,772
192,640
254,382
268,682
Cost of Revenue
11,314
11,314
14,796
24,282
25,629
Gross Profit
187,458
187,458
177,844
230,100
243,053
Operating Expense
228,118
228,118
191,796
223,771
200,888
Operating Income
-40,660
-40,660
-13,952
6,329
42,165
Other Income Expense
17,739
17,739
20,291
4,971
199
Pretax Income
-22,921
-22,921
6,339
11,300
42,364
Tax Provision
-4,021
-4,021
3,830
5,025
9,212
Net Income Common Stockholders
-18,900
-18,900
2,509
6,275
33,152
Diluted NI Available to Com Stockholders
-18,900
-18,900
2,509
6,275
33,152
Basic EPS
-0.29
-0.33
0.04
0.11
0.60
Diluted EPS
-0.29
-0.33
0.04
0.11
0.58
Basic Average Shares
57,955.1730
58,149.0870
57,380.9750
56,461.8770
55,548.1220
Diluted Average Shares
57,995.4170
58,149.0870
57,557.9110
56,983.1710
56,921.8360
Total Operating Income as Reported
-40,660
-40,660
-13,952
6,329
42,165
Total Expenses
239,432
239,432
206,592
248,053
226,517
Net Income from Continuing & Discontinued Operation
-18,900
-18,900
2,509
6,275
33,152
Normalized Income
-18,900
-18,900
2,509
6,275
33,152
EBIT
-40,660
-40,660
-13,952
6,329
42,165
EBITDA
-32,528
-32,528
-10,942
9,062
45,006
Reconciled Cost of Revenue
10,455
10,455
13,876
23,065
24,266
Reconciled Depreciation
8,132
8,132
3,010
2,733
2,841
Net Income from Continuing Operation Net Minority Interest
-18,900
-18,900
2,509
6,275
33,152
Normalized EBITDA
-32,528
-32,528
-10,942
9,062
45,006
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
12/31/2021 - 5/10/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
YB4P.SG Savara Inc
2.8000
-1.41%
NVV1.BE Novavax Inc
6.50
+15.66%
OMGAQ
0.0470
+42.42%
LVTX LAVA Therapeutics N.V.
1.3600
-1.45%
IMNN Imunon, Inc.
0.8766
+0.53%
INZY Inozyme Pharma, Inc.
0.9806
-4.80%
SVRA Savara Inc.
3.2500
+0.93%
IMRX Immuneering Corporation
1.4100
+2.17%
IMMP Immutep Limited
1.6200
+5.88%
TVRD Tvardi Therapeutics, Inc.
18.48
-5.18%